DCF — PRISMA HEALTH TUOMEY HOSPITAL
Enterprise Value: $-111.0M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-111.0M
Enterprise Value
$-37.1M
PV of Cash Flows
$-73.9M
PV of Terminal Value
$-119.0M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $129.3M | $-5.8M | -5.0% | $-11.3M | $-10.3M |
| Year 2 | $133.2M | $-4.7M | -4.0% | $-10.3M | $-8.5M |
| Year 3 | $137.2M | $-3.4M | -3.0% | $-9.2M | $-6.9M |
| Year 4 | $141.3M | $-2.8M | -2.0% | $-8.8M | $-6.0M |
| Year 5 | $145.6M | $-2.5M | -2.0% | $-8.7M | $-5.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-111.0M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$125.6M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.050000001991062595
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5